UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
August 31, 2011
Date of Report (Date of earliest event reported)
ORGENESIS INC.
(Exact name of registrant as specified in its charter)
NEVADA 000-54329 980583166
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
21 Sparrow Circle, White Plains, NY 10605
(Address of principal executive offices) (Zip Code)
+972.4.8242051
(Registrant's telephone number, including area code)
70 Denya St. Haifa Israel, 34980
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
EXPLANATORY NOTE:
This amended current report on Form 8-K/A is being filed to attach a Certificate
of Correction which corrects the par value of the common stock after the stock
split.
ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL
YEAR
Effective August 31, 2011, we completed a merger with our subsidiary, Orgenesis
Inc., a Nevada corporation which was incorporated solely to effect a change in
our name. As a result, we have changed our name from "Business Outsourcing
Services, Inc." to "Orgenesis Inc."
Also effective August 31, 2011 we effected a 35 to one forward stock split of
our authorized and issued and outstanding common and preferred stock. As a
result, our authorized capital has increased from 50,000,000 shares of common
stock with a par value of $0.001 to 1,750,000,000 shares of common stock with a
par value of $0.0001 and our previously outstanding 2,300,000 shares of common
stock increases to 80,500,000 shares of common stock outstanding.
ITEM 7.01 REGULATION FD DISCLOSURE
The name change and forward stock split will become effective with the
Over-the-Counter Bulletin Board at the opening for trading on September 2, 2011
under the current stock symbol "BOUT". A new symbol of "ORGS " will become
effective October 12, 2011 and our stock will commence trading under the symbol
"ORGS" on that date. Our new CUSIP number is 68619K 105.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
3.1 Articles of Merger dated effective August 31, 2011 incorporated by
reference to our current report on Form 8-K filed with the SEC on
September 2, 2011
3.2 Certificate of Change dated effective August 31, 2011 incorporated by
reference to our current report on Form 8-K filed with the SEC on
September 2, 2011
3.3* Certificate of Correction dated February 27, 2012
----------
* attached herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ORGENESIS INC.
By: /s/ Jacob Ben Arie
--------------------------------------
Jacob Ben Arie
Chief Executive Officer and President
March 16, 2012
2